Literature DB >> 24596444

Role of radiation therapy for renal tumors.

Bhupesh Parashar1, Kanhu Charan Patro2, Michael Smith1, Shruthi Arora1, Dattatreyudu Nori1, A Gabriella Wernicke1.   

Abstract

Renal cell carcinoma (RCC) is an aggressive malignancy that carries a poor prognosis, especially in patients presenting with advanced stage. Primary treatment for localized RCC is surgical resection however, a significant number of patients still develop locoregional and distant metastasis after curative resection. In metastatic disease, radiation therapy (RT) has been used for palliation routinely for brain and other extracranial lesions with respectable response rates. However, RT for primary RCC has questionable benefit. In this article, the authors discuss the evidence with regards to the role of RT in primary RCC either as a primary treatment, adjuvant treatment, or preoperatively to improve resection outcomes. In addition, novel RT techniques such as stereotactic body radiation therapy and its use in RCC management are also addressed. Finally, the authors discuss the techniques and doses of RT for primary RCC.

Entities:  

Keywords:  intensity-modulated radiation therapy; radiation; renal; role; stereotactic

Year:  2014        PMID: 24596444      PMCID: PMC3930657          DOI: 10.1055/s-0033-1363847

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  24 in total

Review 1.  A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma.

Authors:  Shankar Siva; Daniel Pham; Suki Gill; Niall M Corcoran; Farshad Foroudi
Journal:  BJU Int       Date:  2012-10-29       Impact factor: 5.588

2.  The value of postoperative radiotherapy in advanced renal cell cancer.

Authors:  R Makarewicz; M Zarzycka; G Kulińska; W Windorbska
Journal:  Neoplasma       Date:  1998       Impact factor: 2.575

3.  [Renal adenocarcinoma; a prospective therapy study in Rotterdam].

Authors:  B van der Werf-Messing; R O van der Heul; R C Ledeboer
Journal:  Ned Tijdschr Geneeskd       Date:  1980-08-02

4.  Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.

Authors:  S Ning; K Trisler; B W Wessels; S J Knox
Journal:  Cancer       Date:  1997-12-15       Impact factor: 6.860

5.  Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.

Authors:  M T Gettman; M L Blute; B Spotts; S C Bryant; H Zincke
Journal:  Cancer       Date:  2001-01-15       Impact factor: 6.860

6.  The value of postoperative irradiation in renal cell cancer.

Authors:  M Stein; A Kuten; J Halpern; N M Coachman; Y Cohen; E Robinson
Journal:  Radiother Oncol       Date:  1992-05       Impact factor: 6.280

7.  Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma.

Authors:  Jonathan J Beitler; Denise Makara; Phillip Silverman; Gil Lederman
Journal:  Am J Clin Oncol       Date:  2004-12       Impact factor: 2.339

8.  Preoperative external beam radiotherapy followed by cytoreductive surgery and intraoperative radiotherapy for locally advanced primary or recurrent renal malignancies.

Authors:  M Frydenberg; L Gunderson; G Hahn; J Fieck; H Zincke
Journal:  J Urol       Date:  1994-07       Impact factor: 7.450

9.  Locally advanced renal cell carcinoma: low complication rate and efficacy of postnephrectomy radiation therapy planned with CT.

Authors:  G D Kao; S B Malkowicz; R Whittington; A V D'Amico; A J Wein
Journal:  Radiology       Date:  1994-12       Impact factor: 11.105

10.  Renal cell cancer stage migration: analysis of the National Cancer Data Base.

Authors:  Christopher J Kane; Katherine Mallin; Jamie Ritchey; Matthew R Cooperberg; Peter R Carroll
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

View more
  2 in total

1.  Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma.

Authors:  Katherine A Murphy; Britnie R James; Yue Guan; Donald S Torry; Andrew Wilber; Thomas S Griffith
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  The Therapeutic Landscape of Renal Cell Carcinoma: From the Dark Age to the Golden Age.

Authors:  Jennifer J Huang; James J Hsieh
Journal:  Semin Nephrol       Date:  2020-01       Impact factor: 5.299

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.